Phorbol ester encjances KAI1 transcription by recruiting Tip60/Pontin complexes

Neoplasia

Volumn 10, Issue 12, 2008, Pages 1421-1432

  Rowe, Alexandra ^a,b   Weiske, Jörg ^c   Kramer, Tobias S ^c   Huber, Otmar ^c,d   Jackson, Paul ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD82 ANTIGEN; HISTONE H3; HISTONE H4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PONTIN; PROTEIN DERIVATIVE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN P50; PROTEIN TIP60; RAF PROTEIN; RAS PROTEIN; REPTIN; UNCLASSIFIED DRUG; CARCINOGEN; CARRIER PROTEIN; HELICASE; HISTONE; HISTONE ACETYLTRANSFERASE; HTATIP PROTEIN, HUMAN; PHORBOL ESTER; RUVBL1 PROTEIN, HUMAN;

ACETYLATION; ARTICLE; CELL STRAIN LNCAP; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; PROTEIN MOTIF; UPREGULATION; ACTIVE TRANSPORT; BIOSYNTHESIS; GENE EXPRESSION REGULATION; METABOLISM; METASTASIS; TUMOR CELL LINE;

ACTIVE TRANSPORT, CELL NUCLEUS; CARCINOGENS; CARRIER PROTEINS; CELL LINE, TUMOR; DNA HELICASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE ACETYLTRANSFERASES; HISTONES; HUMANS; KANGAI-1 PROTEIN; NEOPLASM METASTASIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHORBOL ESTERS; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC;

EID: 57349097159     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.08850     Document Type: Article

References (55)

1. Liu WM and Zhang XA (2006). KAI1/CD82, a tumor metastasis suppressor. Cancer Lett 240, 183-194.
2. Tonoli H and Barrett JC (2005). CD82 metastasis suppressor gene: a potential target for new therapeutics? Trends Mol Med 11, 563-570.
3. Jee B, Jin K, Song HG, and Lee H (2003). Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through a Srcdependent pathway. Exp Mol Med 35, 30-37.
4. Takaoka A, Hinoda Y, Satoh S, Adachi Y, Itoh F, and Adachi M (1998). Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene 16, 1443-1453.
5. Yang JL, Jackson P, Yu Y, Yoshie O, Ham JL, Russell PJ, and Crowe PJ (2001). Invasion and metastasis correlate with down-regulation of KAI1 expression in human colon cancer cell lines. GI Cancer 3, 313-322.
6. Jackson P, Kingsley EA, and Russell PJ (2000). Inverse correlation between KAI1 mRNA levels and cell hehaviour in bladder cancer cell lines. Cancer Lett 156, 9-17.
7. Yang X, Wei LL, Tang C, Slack R, Mueller S, and Lippman ME (2001). Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res 61, 5284-5288.
8. Dong JT, Suzuki H, Pin SS, Bova GS, Schalken JA, Isaacs WB, Barrett JC, and Isaacs JT (1996). Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res 56, 4387-4390.
9. Jackson P, Millar D, Kingsley E, Yardley G, Ow K, Clark S, and Russell PJ (2000). Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancer cell lines. Cancer Lett 157, 169-176.
10. Sekita N, Suzuki H, Ichikawa T, Kito H, Akakura K, Igarashi T, Nakayama T, Watanabe M, Shiraishi T, Toyota M, et al. (2001). Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines. Jpn J Cancer Res 92, 947-951.
11. Gao AC, Lou W, Dong JT, Barrett JC, Danielpour D, and Isaacs JT (2003). Defining regulatory elements in the human KAI1 (CD82) metastasis suppressor gene. Prostate 57, 256-260.
12. Marreiros A, Czolij R, Yardley G, Crossley M, and Jackson P (2003). Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53. Gene 302, 155-164.
13. Kim JH, Choi HJ, Kim B, Kim MH, Lee JM, Kim IS, Lee MH, Choi SJ, Kim KI, Chung CH, et al. (2006). Roles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis. Nat Cell Biol 8, 631-639.
14. Kim JH, Kim B, Cai L, Choi HJ, Ohgi KA, Tran C, Chen C, Chung CH, Huber O, Rose DW, et al. (2005). Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes. Nature 434, 921-926.
15. Akita H, Iizuka A, Hasimoto Y, Kohri K, Ikeda K, and Nakanishi M (2000). Induction of KAI-1 expression in metastatic cancer cells by phorbol esters. Cancer Lett 153, 79-83.
16. Sigala S, Faraoni I, Botticini D, Paez-Pereda M, Missale C, Bonmassar E, and Spano P (1999). Suppression of telomerase, re-expression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines. Clin Cancer Res 5, 1211-1218.
17. Shinohara T, Miki T, Nishimura N, Nokihara H, Hamada H, and Mukaida N (2001). Nuclear factor κB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53. Cancer Res 61, 673-678.
18. Joseph J, Mudduluru G, Antony S, Vashistha S, Ajitkumar P, and Somasundaram K (2004). Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB. Oncogene 23, 6304-6315.
19. Thalmann GN, Sikes RA, Chang SM, Johnston DA, von Eschenbach AC, and Chung LWK (1996). Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer. J Natl Cancer Inst 88, 794-801.
20. Bauer A, Chauvet S, Huber O, Usseglio F, Rothbächer U, Aragnol D, Kemler R, and Pradel J (2000). Pontin52 and Reptin52 function as antagonistic regulators of β-catenin signalling activity. EMBO J 19, 6121-6130.
21. Bauer A, Huber O, and Kemler R (1998). Pontin52, an interaction partner of β-catenin, binds to the TATA box binding protein. Proc Natl Acad Sci USA 95, 14787-14792.
22. Weiske J and Huber O (2005). The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF-β-catenin-mediated transcription. J Cell Sci 118, 3117-3129.
23. Weiske J, Albring KF, and Huber O (2007). The tumor suppressor Fhit acts as a repressor of β-catenin transcriptional activity. Proc Natl Acad Sci USA 104, 20344-20349.
24. Weiske J and Huber O (2006). The histidine triad protein Hint1 triggers apoptosis independent of its enzymatic activity. J Biol Chem 281, 27356-27366.
25. Koivunen J, Aaltonen V, and Peltonen J (2006). Protein kinase C (PKC) family in cancer progression. Cancer Lett 235, 1-10.
26. Song JC, Hanson CM, Tsai V, Farokhzad OC, Lotz M, and Matthews JB (2001). Regulation of epithelial transport and barrier function by distinct protein kinase C isoforms. Am J Physiol Cell Physiol 281, C649-C661.
27. Clarke H, Ginanni N, Laughlin KV, Smith JB, Pettit GR, and Mullin JM (2000). The transient increase of tight junction permeability induced by bryostatin 1 correlates with rapid down-regulation of protein kinase Cα. Exp Cell Res 261, 239-249.
28. Stewart JR and O'Brian CA (2005). Protein kinase C-α mediates epidermal growth factor receptor transactivation in human prostate cancer cells. Mol Cancer Ther 4, 726-732.
29. Hess A, Wijayanti N, Neuschäfer-Rube AP, Katz N, Kietzmann T, and Immenschuh S (2003). Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway. J Biol Chem 278, 45419-45434.
30. Hewson CA, Edbrooke MR, and Johnston SL (2004). PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGFα, Ras/Raf, MEK, ERK and Sp1-dependent mechanisms. J Mol Biol 344, 683-695.
31. Lee HW, Ahn DH, Crawley SC, Li JD, Gum JR Jr, Basbaum CB, Fan NQ, Szymkowski DE, Han SY, Lee BH, et al. (2002). Phorbol 12-myristate 13-acetate up-regulates the transcription of MUC2 intestinal mucin via Ras, ERK, and NF-κB. J Biol Chem 277, 32624-32631.
32. 2. J Biol Chem 279, 48692-48701.
33. Ming XF, Burgering BMT, Wennstrom S, Claesson-Welsh L, Heldin CH, Bos JL, Kozma SC, and Thomas G (1994). Activation of p70/p85 S6 kinase by a pathway independent of rp21ras. Nature 371, 426-429.
34. Tobin D, Nilsson M, and Toftgard R (1996). Ras-independent activation of Rel-family transcription factors by UVB and TPA in cultured keratinocytes. Oncogene 12, 785-793.
35. Hazzalin CA and Mahadevan LC (2002). MAPK-regulated transcription: a continuously variable gene switch? Nat Rev Mol Cell Biol 3, 30-40.
36. Lucas M, Zhang X, Prasanna V, and Mosser DM (2005). ERK activation following macrophage FcγR ligation leads to chromatin modifications at the IL-10 locus. J Immunol 175, 469-477.
37. Pennini ME, Pai RK, Schultz DC, Boom WH, and Harding CV (2006). Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-γ-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signalling. J Immunol 176, 4323-4330.
38. Clayton AL and Mahadevan LC (2003). MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation. FEBS Lett 546, 51-58.
39. Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK, and Rosenfeld MG (2002). Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NFκB and β-amyloid precursor protein. Cell 110, 55-67.
40. Ho PD, Zechner DK, He H, Dillmann WH, Glembotski CC, and McDonough PM (1998). The Raf-MEK-ERK cascade represents a common pathway for alteration of intracellular calcium by Ras and protein kinase C in cardiac myocytes. J Biol Chem 273, 21730-21735.
41. Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, and Ohno KS (1996). Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 271, 23512-23519.
42. Wen-Sheng W (2006). Protein kinase C α trigger Ras- and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2. Cancer Lett 239, 27-35.
43. Clark SS, Zhong L, Filiault D, Perman S, Ren Z, Gould M, and Yang X (2003). Anti-leukemia effect of perillyl alcohol in Bcr/Abl-transformed cells indirectly inhibits signaling through Mek in a Ras- and Raf-independent fashion. Clin Cancer Res 9, 4494-4504.
44. Marreiros A, Dudgeon K, Dao V, Grimm MO, Czolij R, Crossley M, and Jackson P (2005). KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells. Oncogene 24, 637-649.
45. Perissi V and Rosenfeld MG (2005). Controlling nucelar receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol 6, 542-554.
46. Sierra J, Yoshida T, Joazeiro CA, and Jones KA (2006). The APC tumor suppressor counteracts β-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev 20, 586-600.
47. Baek SH (2006). A novel link between SUMO modification and cancer metastasis. Cell Cycle 5, 1492-1495.
48. Cheng J, Bawa T, Lee P, Gong L, and Yeh ETH (2006). Role of desumoylation in the development of prostate cancer. Neoplasia 8, 667-676.
49. Kim JH, Lee JM, Nam HJ, Choi HJ, Yang JW, Lee JS, Kim MH, Kim SI, Chung CH, Kim KI, et al. (2007). SUMOylation of pontin chromatin-remodeling complex reveals a signal integration code in prostate cancer. Proc Natl Acad Sci USA 104, 20793-20798.
50. Gallant P (2007). Control of transcription by Pontin and Reptin. Trends Cell Biol 17, 187-192.
51. Huber O and Weiske J (2008). β-Catenin takes a HIT. Cell Cycle 7, 1326-1331.
52. Huber O, Ménard L, Haurie V, Nicou A, Taras D, and Rosenbaum J (2008). Pontin and Reptin, two related ATPases with multiple roles in cancer. Cancer Res 68, 6873-6876.
53. Lauscher JC, Loddenkemper C, Kosel L, Gröne J, Buhr HJ, and Huber O (2007). Increased pontin expression in human colorectal cancer tissue. Hum Pathol 38, 978-985.
54. Rousseau B, Ménard L, Haurie V, Taras D, Blanc JF, Moreau-Gaudry F, Metzler P, Hugues M, Boyault S, Lemière S, et al. (2007). Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology 46, 1108-1118.
55. Havens AM, Pedersen EA, Shiozawa Y, Ying C, Jung Y, Sun Y, Neeley C, Wang J, Mehra R, Keller ET, et al. (2008). An in vivo mouse model for human prostate cancer metastasis. Neoplasia 10, 371-379.